Arcus Biosciences Statistics
NYSE: RCUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
15.62-0.16 (-1.01%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Arcus Biosciences by the numbers
Arcus Biosciences has a market capitalization of $2.25 billion based on 143.99M shares outstanding. With trailing EPS of $-3.64, Arcus Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.2% below its 50-day average and 35.8% below its 200-day average.
Average daily trading volume is 1.85M shares, or about $28.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RCUS valuation vs. peer median
| Metric | RCUS | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.25B | $2.21B | +2% |
| Avg. volume | 1.85M | 558.03K | +232% |
Peer median across 8 companies: HCM, PHVS, PRGO, NAMS, PBH, LKFT, PVLA, MBX.
Valuation
- Market cap
- $2.25B
- Price / sales (latest FY)
- 9.11
- EPS (TTM)
- $-3.64
- Shares outstanding
- 143.99M
Price and trading
- Previous close
- 15.78
- Open
- 15.66
- Day range
- 15.56 – 16.66
- 52-week range
- 15.56 – 31.74
- 52-week change
- -29.16%
- Beta
- —
- Volume
- 1.67M
- Average volume
- 1.85M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 2.25B
- Forward Pe
- -5.05
- Eps
- -3.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.74
- Week52 Low
- 15.56
- Avg Volume
- 1.85M
- Shares Outstanding
- 143.99M
- Ma50
- 21.47
- Ma200
- 24.34
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -50.78%
- Pct From52w Low
- 0.39%